Cipla USA

Cipla USA, Inc., is a wholly-owned subsidiary of Cipla Limited representing its direct market presence in the U.S. and focused on marketing the highest quality pharmaceutical products in the retail and institutional spaces in the country. The addition of InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc. in 2016, including the manufacturing facilities in New York, strengthened Cipla USA, Inc.'s presence in the U.S. By leveraging Cipla's strong R&D and manufacturing capabilities, Cipla USA, Inc. has been able to build a strong organic pipeline of limited competition complex generic products, and explore an inorganic portfolio of specialty products, all with a view to offering meaningful healthcare solutions to patients in the country. Cipla USA, Inc. is headquartered in Warren, New Jersey, and is today among the most dispensed generic players by prescription.